A study comparing the effect of various schedules of the 7-valent licensed CRM197 - conjugated pneumococcal vaccine (Prevnar) on carriage of Streptococcus pneumoniae in infants and toddlers

Trial Profile

A study comparing the effect of various schedules of the 7-valent licensed CRM197 - conjugated pneumococcal vaccine (Prevnar) on carriage of Streptococcus pneumoniae in infants and toddlers

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jun 2012

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 12 Apr 2010 Results published in the Journal of Infectious Diseases.
    • 29 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top